Skip to main content
PHARMARESEARCH BIO Co., Ltd. logo

PHARMARESEARCH BIO Co., Ltd. — Investor Relations & Filings

Ticker · 217950 ISIN · KR7217950005 KO Manufacturing
Open in API
Filings indexed 162 across all filing types
Latest filing 2023-05-26 Capital/Financing Update
Country KR South Korea
Listing KO 217950

About PHARMARESEARCH BIO Co., Ltd.

http://www.pr-bio.co.kr/eng/

PHARMARESEARCH BIO Co., Ltd. is a biopharmaceutical company specializing in regenerative medicine. The company leverages marine biotechnology to research, develop, and produce innovative biological products aimed at enhancing human health. Its core activities center on the development of raw materials for cell and tissue regeneration, such as Polydeoxyribonucleotide (PDRN) and Polynucleotide (PN) derived from salmon DNA. The company's research and development pipeline also includes other biological products, such as toxin-based therapeutics, to address various medical and aesthetic needs.

Recent filings

Filing Released Lang Actions
전환가액의조정(제4회차)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory announcement regarding the adjustment of the conversion price for convertible bonds (CB) due to a decline in market price. This type of filing, which details changes to the capital structure or financing terms (specifically conversion price adjustments for debt instruments), falls under the 'Capital/Financing Update' category.
2023-05-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회 결과' (Regular General Meeting of Shareholders Results) and details the outcomes of the voting items (approval of financial statements, director re-election, and compensation limits) held on 2023-03-30. This matches the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA).
2023-03-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in South Korea. This type of filing is a mandatory disclosure by company insiders (directors/executives) regarding their personal share transactions and holdings. According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2023-03-28 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for PharmaResearch Bio, covering the fiscal year 2022 (2022.01.01-2022.12.31). It contains comprehensive company information, including governance, capital structure, business overview, financial data, and risk management. In the context of Korean corporate filings, the 'Business Report' (사업보고서) is the equivalent of the annual comprehensive report filed with the Financial Supervisory Service (FSS), which corresponds to the 10-K filing category. FY 2022
2023-03-22 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a short regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Pharma Research Bio. It provides a summary table of audit opinions and key financial figures (assets, liabilities, net income) as reported by the external auditor. Since it is a brief regulatory announcement regarding the submission of an audit report rather than the full, comprehensive audit report document itself, it falls under the category of a Report Publication Announcement. FY 2022
2023-03-21 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for PharmaResearchBio. It contains the agenda for the Annual General Meeting (AGM), including the approval of financial statements, director re-election, and remuneration limits. It also includes management's business report and financial statements as reference materials for the meeting. This document is a standard proxy statement/notice for an AGM, which falls under the 'Proxy Solicitation & Information Statement' category.
2023-03-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.